TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 4 | 3 | 14 | 40 | 16 | -49 | 5 |
| S | %wins | 50 | 50 | 50 | 25 | 50 | 100 | 54 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/12 14:58 | 3/2/12 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | McCullough David | NC | O | VP | S.d | -3 | 4.78 | 2 | -1 | -4 | 14 | D | -30 | 12 | 42 | 63 | 65 | 22 | 12 | 4 | 19 | 19 | 6 | -38 | -9 | -74 |
1/5/12 13:47 | 1/3/12 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | McCullough David | NC | O | VP | M.d | 73 | 1.20 | 0 | 61 | 6 | D | -67 | -55 | -37 | -8 | -11 | -3 | -5 | 2 | 3 | 4 | 67 | 96 | 63 | -32 | |
1/5/12 13:47 | 1/3/12 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | McCullough David | NC | O | VP | S.d | -149 | 2.45 | 0 | -61 | -91 | 6 | D | -67 | -55 | -37 | -8 | -11 | -3 | -5 | 2 | 3 | 4 | 67 | 96 | 63 | -32 |
12/8/11 14:41 | 12/7/11 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | McCullough David | NC | O | VP | S | -13 | 2.85 | 0 | -5 | -43 | 6 | D | -57 | -41 | -13 | -3 | -7 | -2 | 6 | -3 | -5 | -13 | -13 | 95 | 24 | -50 |
1/25/10 14:12 | 1/22/10 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | McCullough David | AL | O | VP | S | -100 | 7.02 | 11 | -14 | -72 | 6 | D | 29 | 241 | -21 | -29 | -3 | 6 | -15 | -16 | -1 | 0 | -4 | 8 | -15 | -38 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |